A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Hepatology · 2,642 citations
https://doi.org/10.1097/hep.0000000000000520
S
Sven Francque
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
447
Papers
34.0K
Citations
79
h-index
194
i10-index
Sven Francque is an academic researcher from Inova Health System. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Diet, Metabolism, and Disease. The author has an h-index of 79, co-authored 380 publications.
ORCID: 0000-0002-7527-4714Papers by this author
worksA multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Journal of Hepatology · 2,472 citations
https://doi.org/10.1016/j.jhep.2023.06.003
Baveno VII – Renewing consensus in portal hypertension
2021 · Journal of Hepatology · 2,388 citations
https://doi.org/10.1016/j.jhep.2021.12.022
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2024 · New England Journal of Medicine · 1,494 citations
https://doi.org/10.1056/nejmoa2309000
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 · Journal of Hepatology · 1,232 citations
https://doi.org/10.1016/j.jhep.2024.04.031
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
2019 · The Lancet · 1,172 citations
https://doi.org/10.1016/s0140-6736(19)33041-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat